S-32 Application of nanomaterials for drug innovation and their risk   S32-1. Effect of nanomaterials on the induction of cell death   S32-2. Toxicity testing and assessment of nanomatrials   S32-3. Present Status of Health Effect Studies on Nanomaterials   S32-4. Present status of nanomaterial carcinogenic risk assessment   S32-5. Percutaneous assessment of nanomaterial titanium dioxide in cosmetics   S32-6. Efficacy and safety of γ-PGA nanoparticles as vaccine carrier